imiquimod has been researched along with Female Genital Neoplasms in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Jonnalagadda, S; Palle, K; Reedy, M | 1 |
Bevilacqua, F; Bleeker, MCG; Bornstein, J; Carcopino, X; Chargari, C; Cruickshank, ME; Erzeneoglu, BE; Esat Temiz, B; Gallio, N; Gultekin, M; Heller, D; Joura, E; Kesic, V; Planchamp, F; Preti, M; Querleu, D; Reich, O; Stockdale, CK; Van Beurden, M; Vieira-Baptista, P; Woelber, L; Zodzika, J | 1 |
Campagne, G; MartÃnez, A; Roca, M | 1 |
Berencsi, G; Melles, M; Sziller, I | 1 |
Misery, L | 1 |
Gollnick, HP; Law, C; Marini, M; O'Mahony, C | 1 |
Arany, I; Diaz-Arrastia, C; Dinh, TV; Gatalica, Z; Hannigan, E; Robazetti, SC; Tyring, SK | 1 |
1 review(s) available for imiquimod and Female Genital Neoplasms
Article | Year |
---|---|
[Prevention of malignant tumors caused by human papilloma virus (HPV) by vaccination and with the methods of classical gynecologic diagnostics].
Topics: Adjuvants, Immunologic; Adolescent; Aminoquinolines; Antineoplastic Agents; Biopsy; Cell Transformation, Neoplastic; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Male; Papanicolaou Test; Papillomaviridae; Papillomavirus Infections; Tumor Virus Infections; Vaginal Smears; Viral Vaccines | 2006 |
6 other study(ies) available for imiquimod and Female Genital Neoplasms
Article | Year |
---|---|
Case Report: Intra-Tumoral Vaccinations of Quadrivalent HPV-L1 Peptide Vaccine With Topical TLR-7 Agonist Following Recurrence: Complete Resolution of HPV-HR-Associated Gynecologic Squamous Cell Carcinomas in Two Patients.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Imiquimod; Neoplasm Recurrence, Local; Papillomavirus Infections; Salvage Therapy; Toll-Like Receptor 7 | 2021 |
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) consensus statem
Topics: Carcinoma in Situ; Cidofovir; Colposcopy; Female; Genital Neoplasms, Female; Humans; Imiquimod; Melanoma; Melanoma, Cutaneous Malignant; Paget Disease, Extramammary; Pregnancy; Skin Neoplasms; Vulvar Neoplasms | 2022 |
Successful treatment of a high-grade intraepithelial neoplasia with imiquimod, with vulvar pemphigus as a side effect.
Topics: Adjuvants, Immunologic; Adult; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Female; Genital Neoplasms, Female; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Pemphigus; Treatment Outcome; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Diseases; Vulvar Neoplasms | 2003 |
Treatment of genital Paget's skin disease with topical imiquimod: severe adverse events.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Diagnosis, Differential; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Imiquimod; Paget Disease, Extramammary | 2007 |
New patient-applied therapy for anogenital warts is rated favourably by patients.
Topics: Administration, Topical; Adolescent; Adult; Aminoquinolines; Antineoplastic Agents; Anus Neoplasms; Female; Follow-Up Studies; Genital Neoplasms, Female; Genital Neoplasms, Male; Health Knowledge, Attitudes, Practice; Humans; Imiquimod; Male; Surveys and Questionnaires; Time Factors; Treatment Outcome; Warts | 2001 |
Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
Topics: 2',5'-Oligoadenylate Synthetase; Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Female; Follow-Up Studies; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Genital Neoplasms, Female; Humans; Imiquimod; Middle Aged; Ointments; RNA, Neoplasm; Time Factors; Treatment Outcome; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2001 |